Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207,440,936
-
Total 13F shares
-
20,787,063
-
Share change
-
+2,958,026
-
Total reported value
-
$962,036,441
-
Put/Call ratio
-
377%
-
Price per share
-
$46.28
-
Number of holders
-
129
-
Value change
-
+$142,703,625
-
Number of buys
-
62
-
Number of sells
-
62
Institutional Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q2 2017
As of 30 Jun 2017,
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,787,063 shares.
The largest 10 holders included
Pentwater Capital Management LP, BB BIOTECH AG, STATE STREET CORP, FMR LLC, BlackRock Inc., CREDIT SUISSE AG/, Boxer Capital, LLC, DISCOVERY CAPITAL MANAGEMENT, LLC / CT, Aisling Capital LLC, and VANGUARD GROUP INC.
This page lists
129
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.